1 No FDA approval FOR NEW LABEL for AFREZZA. 2 No big jump in new RX's for AFREZZA. 3 AFREZZA still at tier 3 insurance. 4 REV = 0 5 Another dilution coming soon due to 50 million cash loan settlement. 414 million shares out standing. 6 NO AD on TV for AFREZZA. 7 NO NEW bonus of 25 million from SNY. 8 NO completion of lung cancer study promised FDA 9 NO AFREZZA approval for children.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.